ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.650,03
0,00%
S&P 500
5.307,01
0,00%
US Dollar vs BRL
5,13
-0,44%
Bitcoin
69.723,36
0,90%
Brent Oil
82,425
1,10%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Ayala Pharmaceuticals Inc (PK) (ADXS)

  7. Ayala Pharmaceuticals Inc (PK) (ADXS) Notícias

ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ADXS
DataHoraFonteTítuloCódigoCompanhia
06/03/202409:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202418:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202410:16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202419:22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202418:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202413:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202418:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202311:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202318:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202318:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202312:46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202317:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202307:13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
11/09/202313:38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/05/202314:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/05/202317:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
07/04/202318:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/04/202318:24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
10/02/202308:08Edgar (US Regulatory)Annual Report (10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/02/202319:20Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202318:52Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202308:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/01/202320:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/01/202318:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202208:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202208:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/12/202218:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/06/202207:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/05/202217:55Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
28/03/202209:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Apresentando as notícias mais relevantes sobre:USOTC:ADXS

Seu Histórico Recente

EU
ZSBTP
Euronext Eurozone SBT 15
LSE
38CS
Soybean Oil Mro
BITMOT
984481
Campari Tf 4,71% Mg30 Ca...
ASX
IAAJOZ
TSXV
GBML
Global Battery Metals
BIT
P1XMN1
NLBNPIT1XMN1 20240620 39...
BIT
P1ZHO4
NLBNPIT1ZHO4 20240918 17...
ASX
FGH
Foresta
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados